11.11.2021
Today, the European Medicines Agency (EMA) has given a positive opinion on two COVID-19 treatments - Ronapreve and Regkirona - identified by the Commission as promising therapeutics under the EU Strategy on COVID-19 Therapeutics. Both are treatments for use during the early stages of infection based on antiviral monoclonal antibodies.
